| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,592 |
8,982 |
$644K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,427 |
3,364 |
$386K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,240 |
3,171 |
$366K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,001 |
7,466 |
$282K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,146 |
2,116 |
$253K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,997 |
1,902 |
$203K |
| 97802 |
|
7,308 |
7,167 |
$61K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,944 |
6,791 |
$53K |
| 92283 |
|
7,132 |
6,990 |
$48K |
| 99188 |
|
3,113 |
3,041 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,142 |
1,067 |
$14K |
| 90670 |
|
1,760 |
1,730 |
$13K |
| 99381 |
|
146 |
142 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,037 |
978 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
220 |
220 |
$7K |
| 99050 |
|
1,055 |
1,022 |
$5K |
| 90700 |
|
317 |
309 |
$4K |
| 90698 |
|
215 |
212 |
$4K |
| 99383 |
|
31 |
31 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
850 |
815 |
$4K |
| 87807 |
|
366 |
355 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
730 |
652 |
$4K |
| 90723 |
|
875 |
856 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
27 |
26 |
$3K |
| 90686 |
|
824 |
811 |
$3K |
| 90734 |
|
924 |
917 |
$2K |
| 90633 |
|
1,060 |
1,038 |
$2K |
| 85018 |
|
1,711 |
1,667 |
$2K |
| 90707 |
|
446 |
433 |
$2K |
| 94664 |
|
612 |
548 |
$2K |
| 90744 |
|
131 |
124 |
$2K |
| 90651 |
|
932 |
923 |
$2K |
| 90715 |
|
383 |
380 |
$2K |
| 85014 |
|
1,611 |
1,565 |
$1K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
8,436 |
7,930 |
$1K |
| 99051 |
|
437 |
433 |
$818.01 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
564 |
503 |
$675.62 |
| 90648 |
|
295 |
284 |
$578.91 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
147 |
101 |
$559.66 |
| 90716 |
|
429 |
414 |
$316.41 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
44 |
44 |
$269.10 |
| 90696 |
|
227 |
225 |
$251.12 |
| 92551 |
|
1,253 |
1,211 |
$193.50 |
| 81002 |
|
151 |
145 |
$166.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
44 |
30 |
$158.15 |
| 90620 |
|
64 |
63 |
$136.24 |
| 90647 |
|
753 |
742 |
$102.66 |
| 90713 |
|
75 |
69 |
$49.15 |
| 90685 |
|
18 |
18 |
$28.87 |
| 94760 |
|
657 |
576 |
$4.94 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
710 |
606 |
$2.64 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
101 |
98 |
$0.00 |
| 96127 |
|
400 |
396 |
$0.00 |
| 99000 |
|
12 |
12 |
$0.00 |
| 90710 |
|
246 |
246 |
$0.00 |
| 90681 |
|
329 |
324 |
$0.00 |